Results 161 to 170 of about 61,569 (245)

Angiotensin-converting enzyme inhibitors vs. receptor blockers in heart failure with mildly reduced ejection fraction. [PDF]

Front Cardiovasc Med
Weidner K, Behnes M, Reinhardt M, Abel N, Schmitt A, Lau F, Steffen HJ, Hetjens S, Duerschmied D, Akin I, Schupp T.   +10 more
europepmc   +1 more source

Oxaliplatin‐induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose–response relationship and impact on quality of life

International Journal of Cancer, Volume 159, Issue 1, Page 198-209, 1 July 2026.
What's New? Oxaliplatin serves a key role in the treatment of rectal cancer, though it is a significant cause of chemotherapy‐induced peripheral neuropathy. As total neoadjuvant therapy, in which all therapy is given before surgery, has become more common, understanding neuropathy has grown increasingly important. This study examined neuropathy and its
Georg W. Wurschi, Andreas Hinz, Melanie Schneider, Jan‐Niklas Becker, Bernd Frerker, Samuel M. Vorbach, Felix Ehret, Markus Diefenhardt, Fabian Schunn, Maria‐Elena von Gruben, Marcel Büttner, Elgin Hoffmann, Alexander Rühle, Josephine Beier, Simone Ferdinandus, Maike Trommer, Ezgi Ceren Sahin, Julian Hlouschek, Kynann Aninditha, Daphne Schepers von Ohlen, Justus Kaufmann, Alina Depardon, Hai Minh Ha, Christopher Kessler, Adrianna Cieslak, Simon Trommer, Alexander Fabian, Florian Rißner, Maximilian Römer, Klaus Pietschmann   +29 more
wiley   +1 more source

Does the management of anastomotic leakage after rectal cancer resection affect long-term oncological survival? A retrospective propensity score-adjusted cohort study. [PDF]

Tech Coloproctol
Ammann Y, Marti L, Warschkow R, Bischofberger S, Reißfelder C, Schmied B, Brunner W, Tarantino I.   +7 more
europepmc   +1 more source

Real‐world progression‐free survival and overall survival in patients with HR+/HER2− advanced breast cancer treated in first‐line with ribociclib, endocrine monotherapy or chemotherapy: Results from the observational RIBANNA study

International Journal of Cancer, Volume 159, Issue 1, Page 210-223, 1 July 2026.
What's New? The CDK4/6 inhibitor ribociclib in combination with an endocrine‐based therapy has demonstrated significant progression‐free and overall survival benefits in patients with advanced/metastatic HR+/HER2‐ breast cancer in the pivotal MONALEESA trials.
Peter A. Fasching, Cosima Brucker, Thomas Decker, Anne Engel, Thomas Göhler, Christian Jackisch, Jan Janssen, Andreas Köhler, Kerstin Lüdtke‐Heckenkamp, Diana Lüftner, Frederik Marmé, Marion van Mackelenbergh, Beate Rautenberg, Marcus Schmidt, Rudolf Weide, Pauline Wimberger, Elena Kisseleff, Christina Pfister, Claudia Quiering, Christian Roos, Achim Wöckel   +20 more
wiley   +1 more source

An investigation into the statistical precision attainable with a distribution-free method of constructing age-dependent reference centiles. [PDF]

PLoS One
Wellek S.
europepmc   +1 more source

A Microfluidic Gradient Generator Post‐Modified by Two‐Photon Direct Laser Writing for Dynamic Particle Functionalization

Journal of Applied Polymer Science, Volume 143, Issue 21, June 5, 2026.
We present a Christmas‐tree‐shaped microfluidic gradient generator (MGG) that is equipped with dynamic trapping chambers, based on thermoresponsive microactuators. At room temperature, amine‐functionalized polystyrene beads are trapped inside the pNIPAM funnels and fluorescently labeled.
Chantal Barwig, Valerio Chionna, Annabelle Sonn, Kathi Michèle Kaiser, Zhe Wang, Christine Selhuber‐Unkel, Sadaf Pashapour   +6 more
wiley   +1 more source

Associations of biomarkers with hypoattenuated leaflet thickening after transcatheter aortic valve replacement. [PDF]

Res Pract Thromb Haemost
Hesselbarth D, D'Orazio M, Ciccarone G, Gjermeni D, Jülch C, Breitbart P, Ruile P, Hein M, Wessinger M, Maslarska M, Rilinger J, Schlett C, Bamberg F, Kaier K, Duerschmied D, Pottgiesser T, von Zur Mühlen C, Westermann D, Olivier CB.   +18 more
europepmc   +1 more source

MYCN Amplification in RB1‐Inactivated Retinoblastoma: Association With High‐Risk Features

Pediatric Blood &Cancer, Volume 73, Issue 6, June 2026.
ABSTRACT Background MYCN amplification occurs in a subset of retinoblastoma cases, both with and without RB1 inactivation. It has been suggested that retinoblastomas with MYCN amplification represent a distinct entity with more aggressive clinical behavior.
Kyriaki Papaioannou, Regina Kubica, Karen Fischhuber, Jasmin Beygo, Madlen Reschke, Petra Ritter‐Sovinz, Eva Biewald, Petra Ketteler, Dietmar Lohmann, Deniz Kanber   +9 more
wiley   +1 more source

Autoantibodies as predictors for immune-related adverse events in checkpoint inhibition therapy of metastatic melanoma. [PDF]

J Immunother Cancer
Reschke R, Budde P, Zucht HD, Mangana J, Dummer R, Pfoehler C, Wistuba-Hamprecht K, Weide B, Hakim-Meibodi LE, Meier F, Schulz C, Richter J, Bräutigam M, Gutjahr C, Schulz-Knappe P, Hassel JC.   +15 more
europepmc   +1 more source

Method Comparison of Dried Blood Spot and Plasma Apolipoprotein B Measurement on a Semi‐Automated Analyser: Toward Accessible Lipid Profiling in Resource‐Limited Settings

Analytical Science Advances, Volume 7, Issue 1, June 2026.
ABSTRACT Apolipoprotein B (ApoB) is a key marker of atherogenic lipoprotein burden, but conventional plasma‐based testing requires venous sampling and centralized laboratory infrastructure. Dried blood spot (DBS) sampling offers a minimally invasive alternative suitable for decentralized settings.
Bronwyn Pitampersad, Savathree Madurai, Bhavani Manivannan, Kayla Pillay, Sharana Mahomed   +4 more
wiley   +1 more source